McKesson Corporation (MCK)
NYSE: MCKHealth CareOther PharmaceuticalsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 910.33 0.00%
MCK stock chart
Technical analysisKey statistics
All statistics- Market cap
- $106.14B
- P/E (TTM)
- 24.24
- Forward P/E
- 18.04
- EPS (TTM)
- $37.56
- Dividend yield
- 0.36% ($3.28)
- Ex-dividend date
- Sep 1, 2026
- 52-week range
- 723.68 – 999.00
- Day range
- 908.57 – 933.99
- Volume / Avg
- 794.40K / 927.72K
- Beta
- —
- Shares outstanding
- 116.59M
- Next earnings
- Nov 4, 2026
52-week range
MCK stock today
McKesson (MCK) closed at $910.33 on Oct 7, down 1.23% (-$11.34), versus the S&P 500's 0.22% decline. Shares are 8.9% below their 52-week high of $999.00, set on Mar 3, 2026 and 25.8% above the 52-week low of $723.68, in the middle of the past year's range. MCK is up 11.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 21.4%.
At 24.2x trailing earnings, McKesson trades in line with the peer-group median of 23.6x. Its forward P/E of 18.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. McKesson's next earnings report is expected on Nov 4, 2026. McKesson pays an annual dividend of $3.28 per share, a 0.36% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About McKesson
Company profileMcKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Mr. Brian S. Tyler Ph.D.
- Headquarters
- Irving, TX
- Employees
- 41,600
- Website
- mckesson.com
Financial highlights
Full financialsIn fiscal 2026, McKesson generated $403.43 billion in revenue, up 12.4% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $4.76 billion (+44.5% year over year), for a net margin of 1.2% versus a median of 0.9% in the prior 5 years. Gross margin was 3.6% (down from 3.7%) and operating margin 1.5%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $403.43B | $359.05B | $308.95B | $276.71B | $263.97B |
| Growth | +12.36% | +16.22% | +11.65% | +4.83% | +10.80% |
| Net income | $4.76B | $3.29B | $3.00B | $3.56B | $1.11B |
| EPS (diluted) | $38.38 | $25.72 | $22.39 | $25.03 | $7.23 |
Analyst forecast
ForecastConsensus (15 analysts)
buy
Avg. price target
$977.33+7.36%
- Strong buy 3
- Buy 9
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $10.77
- Last reported (Q1 2027)
- Aug 5, 2026
- EPS actual vs est.
- $5.15 vs —
Dividends
Dividend history- Annual dividend
- $3.28
- Dividend yield
- 0.36%
- Last payment
- $0.94
- Ex-dividend date
- Sep 1, 2026
MCK news
All MCK news- Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"Nasdaq
- Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?Nasdaq
- Why Option Care Health Stock Skyrocketed on TuesdayNasdaqOPCH, MCK
- Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R TakeoverInvestor's Business Daily
- OPCH shares jump 34% as CD&R, McKesson agree to $5.8B takeoverSeeking Alpha
- CD&R And McKesson To Acquire Option Care HealthNasdaqMCK, OPCH
- Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDexNasdaqBDX, CAH, MCK, MMSI
- Company News for Oct 2, 2026NasdaqACN, MCK, PRGS, AYI
McKesson peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CORCencora Inc. | 317.25 | +0.28% | $60.54B | vs MCK |
| CAHCardinal Health Inc. | 232.16 | -0.55% | $53.76B | vs MCK |
| HLFHerbalife Ltd. | 12.65 | +0.56% | $1.31B | vs MCK |
| NUSNu Skin Enterprises Inc. | 4.80 | +1.27% | $233.65M | vs MCK |
| ZSTKZeroStack Corp. | 4.77 | +0.42% | $103.97M | vs MCK |
| ESYNEnerSyn Global Inc. | 2.06 | -1.90% | $61.24M | vs MCK |
| COSMCosmos Health Inc. | 0.3209 | +0.44% | $32.29M | vs MCK |
| MEDSDataMeds AI Inc. | 2.88 | -6.19% | $8.16M | vs MCK |
Indexes, lists and sector
Index membership
Appears in lists
McKesson stock FAQ
What is McKesson's stock price today?
MCK last traded at $910.33 as of Oct 7, 4:00 PM EDT, down 1.23% on the day. Prices are delayed at least 15 minutes.
Does McKesson pay a dividend?
Yes. McKesson pays $3.28 per share annually, a 0.36% yield. The most recent dividend of $0.94 had an ex-dividend date of Sep 1, 2026.
When is McKesson's next earnings date?
McKesson is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $10.77.
What is MCK's P/E ratio?
MCK trades at a trailing P/E ratio of 24.24 and a forward P/E of 18.04, compared with a median of 23.6 for its closest peers.
Is McKesson in the S&P 500?
Yes. McKesson (MCK) is a constituent of the S&P 500 index.
Who is McKesson's CEO?
Mr. Brian S. Tyler Ph.D. is the chief executive officer of McKesson Corporation, which has about 41,600 employees.
Has MCK ever split its stock?
Yes. The most recent MCK stock split was a 2-for-1 split on Jan 5, 1998.